Hydroxyzine pamoate | CAS#10246-75-0 |

MedKoo Cat#: 593006 | Name: Hydroxyzine pamoate

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Hydroxyzine pamoate is an histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness.

Chemical Structure

Hydroxyzine pamoate

CAS#10246-75-0

Theoretical Analysis

MedKoo Cat#: 593006

Name: Hydroxyzine pamoate

CAS#: 10246-75-0

Chemical Formula: C44H43ClN2O8

Exact Mass: 762.2708

Molecular Weight: 763.28

Elemental Analysis: C, 69.24; H, 5.68; Cl, 4.64; N, 3.67; O, 16.77

Price and Availability

Size	Price	Availability	Quantity
50mg	USD 300.00	2 Weeks
100mg	USD 550.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

Hydroxyzine pamoate

IUPAC/Chemical Name

Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, compd. with 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic acid) (1:1)

InChi Key

ASDOKGIIKXGMNB-UHFFFAOYSA-N

InChi Code

InChI=1S/C23H16O6.C21H27ClN2O2/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-10,24-25H,11H2,(H,26,27)(H,28,29);1-9,21,25H,10-17H2

SMILES Code

ClC1=CC=C(C(N2CCN(CCOCCO)CC2)C3=CC=CC=C3)C=C1.O=C(C4=C(O)C(CC5=C6C=CC=CC6=CC(C(O)=O)=C5O)=C7C=CC=CC7=C4)O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 763.28 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Montazeri M, Mehrzadi S, Sharif M, Sarvi S, Shahdin S, Daryani A. Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review. Parasitol Res. 2018 Aug 8. doi: 10.1007/s00436-018-6027-z. [Epub ahead of print] Review. PubMed PMID: 30088074. 2: Chalavi S, Fakhari AR, Nojavan S. Development of a modified partial filling method in capillary electrophoresis using two chiral plugs for the simultaneous enantioseparation of chiral drugs: Comparison with mixed chiral selector capillary electrophoresis. J Chromatogr A. 2018 Sep 14;1567:211-218. doi: 10.1016/j.chroma.2018.06.052. Epub 2018 Jun 21. PubMed PMID: 30064817. 3: Allen SA, Tomilov A, Cortopassi GA. Small molecules bind human mTOR protein and inhibit mTORC1 specifically. Biochem Pharmacol. 2018 Jul 17;155:298-304. doi: 10.1016/j.bcp.2018.07.013. [Epub ahead of print] PubMed PMID: 30028993. 4: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK500985/ PubMed PMID: 30000044. 5: Kapuganti A, Turner T, Thomas CJ. Evaluation of buprenorphine/naloxone dose and use of sedating supportive medication on treatment outcomes in veterans with opioid use disorder. Ment Health Clin. 2018 Mar 23;7(6):271-275. doi: 10.9740/mhc.2017.11.271. eCollection 2017 Nov. PubMed PMID: 29955533; PubMed Central PMCID: PMC6007732. 6: East N, Maroney M. Topiramate in the treatment of Prader-Willi syndrome: A case report. Ment Health Clin. 2018 Mar 23;7(1):7-9. doi: 10.9740/mhc.2017.01.007. eCollection 2017 Jan. PubMed PMID: 29955490; PubMed Central PMCID: PMC6007661. 7: Chalavi S, Fakhari AR, Nojavan S, Mirzaei P. Evaluation of the synergistic effect with amino acids for enantioseparation of basic drugs using capillary electrophoresis. Electrophoresis. 2018 Jun 26. doi: 10.1002/elps.201800128. [Epub ahead of print] PubMed PMID: 29947135. 8: Murayama N, Murayama K. Data on various allergen specific IgEs and prospective treatments on food-dependent exercise-induced anaphylaxis. Data Brief. 2018 May 5;18:1895-1899. doi: 10.1016/j.dib.2018.04.097. eCollection 2018 Jun. PubMed PMID: 29904693; PubMed Central PMCID: PMC5998299. 9: Etemad L PharmD PhD, Moshiri M MD PhD, Balali-Mood M MD PhD. Delayed Complications and Long-Term Management of Sulfur Mustard Poisoning: A Narrative Review of Recent Advances by Iranian Researchers Part ІІ: Clinical Management and Therapy. Iran J Med Sci. 2018 May;43(3):235-247. Review. PubMed PMID: 29892141; PubMed Central PMCID: PMC5993908. 10: Avdagic K, Geier M, Coralic Z, Finley P. Evaluation of the Impact of a Multimodel Intervention on Prescribing Patterns of Sedative-Hypnotics in a Behavioral Health System. Prim Care Companion CNS Disord. 2018 May 31;20(3). pii: 18m02269. doi: 10.4088/PCC.18m02269. PubMed PMID: 29873949. 11: Maciel-Guerra H, Penha MÁ, Jorge MFS, Libório RDS, Carrijo ACNDA, Parise-Fortes MR, Miot HA. Suppression of wheal and flare in histamine test by the main H1 antihistamines commercialized in Brazil. An Bras Dermatol. 2018 Mar;93(2):233-237. doi: 10.1590/abd1806-4841.20186807. PubMed PMID: 29723372; PubMed Central PMCID: PMC5916396. 12: Oh S, Kingsley K. Efficacy of Ketamine in Pediatric Sedation Dentistry: A Systematic Review. Compend Contin Educ Dent. 2018 May;39(5):e1-e4. PubMed PMID: 29714490. 13: Bosak M, Cyranka K, Dudek D, Kowalik M, Mołek P, Słowik A. Psychiatric comedication in patients with epilepsy. Epilepsy Behav. 2018 Jun;83:207-211. doi: 10.1016/j.yebeh.2018.03.033. Epub 2018 Apr 26. PubMed PMID: 29706306. 14: Flórez Borges P, García-Montoya E, Pérez-Lozano P, Jo E, Miñarro M, Manich A, Suñé-Negre JM. The role of SeDeM for characterizing the active substance and polyvinyilpyrrolidone eliminating metastable forms in an oral lyophilizate-A preformulation study. PLoS One. 2018 Apr 24;13(4):e0196049. doi: 10.1371/journal.pone.0196049. eCollection 2018. PubMed PMID: 29689061; PubMed Central PMCID: PMC5916852. 15: Poleszczyk A, Rakowicz M, Parnowski T, Antczak J, Święcicki Ł. Are there clinical and neurophysiologic predictive factors for a positive response to HF-rTMS in patients with treatment-resistant depression? Psychiatry Res. 2018 Jun;264:175-181. doi: 10.1016/j.psychres.2018.03.084. Epub 2018 Apr 3. PubMed PMID: 29649674. 16: Katselou M, Athanaselis S, Nikolaou P, Qammaz S, Dona A, Spiliopoulou C, Papoutsis I. A fully validated method for the simultaneous determination of 11 antihistamines in breast milk by gas chromatography-mass spectrometry. Biomed Chromatogr. 2018 Aug;32(8):e4260. doi: 10.1002/bmc.4260. Epub 2018 May 28. PubMed PMID: 29644705. 17: KalantarMotamedi Y, Eastman RT, Guha R, Bender A. A systematic and prospectively validated approach for identifying synergistic drug combinations against malaria. Malar J. 2018 Apr 11;17(1):160. doi: 10.1186/s12936-018-2294-5. PubMed PMID: 29642892; PubMed Central PMCID: PMC5896032. 18: Godse K, De A, Zawar V, Shah B, Girdhar M, Rajagopalan M, Krupashankar DS. Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update. Indian J Dermatol. 2018 Jan-Feb;63(1):2-15. doi: 10.4103/ijd.IJD_308_17. Review. PubMed PMID: 29527019; PubMed Central PMCID: PMC5838750. 19: Daens S, Grossin D, Hermanns-Lê T, Peeters D, Manicourt D. [Severe Mast Cell Activation Syndrome in a 15-year-old patient with an hypermobile Ehlers-Danlos syndrome]. Rev Med Liege. 2018 Feb;73(2):61-64. French. PubMed PMID: 29517867. 20: Schaefer M, Sahin T, Berstecher B. Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis. PLoS One. 2018 Mar 7;13(3):e0192758. doi: 10.1371/journal.pone.0192758. eCollection 2018. PubMed PMID: 29513699; PubMed Central PMCID: PMC5841659.